Rep. James R. Walkinshaw

Maddy summary# Summary of the Agriculture Resilience Act of 2025 This comprehensive legislative proposal aims to transform U.S. agricultural systems to be more resilient, sustainable, and climate-smart while addressing food waste and improving food safety labeling. ## Key Provisions ### Conservation & Climate Resilience - **Conservation Reserve Program** (Section 504): Expands enrollment targets through 2030 and establishes a new "Grassland 30" contract option for long-term grassland conservation. - **Private Grazing Land Conservation** (Section 503): Focuses on soil health, climate resilience, and transitioning from confinement systems to managed grazing systems. - **Alternative Manure Management Program** (Section 505): Supports dairy and livestock producers in adopting practices that reduce methane emissions and improve carbon sequestration. ### Renewable Energy - **Rural Energy for America Program** (Section 601): Expands to support renewable energy development and greenhouse gas emissions reductions. - **Agrivoltaic Systems** (Section 602): Mandates research on integrated solar energy and agricultural production systems. - **AgSTAR Program** (Section 603): Maintains and expands the anaerobic digestion program to reduce methane emissions from livestock waste. ### Food Loss & Waste Reduction - **Standardized Food Date Labeling** (Section 701-705): Establishes uniform "BEST If Used By" (quality date) and "USE By" (discard date) phrases to reduce confusion and food waste. - **Composting as Conservation Practice** (Section 711): Officially recognizes composting as a conservation practice under USDA programs. - **Federal Food Donation Act Amendments** (Section 712): Requires federal contractors to donate excess food and report on food waste. - **School Food Waste Reduction** (Section 714): Creates grant program for schools to measure, prevent, and reduce food waste. - **Food Waste Research Program** (Section 716): Establishes regional research centers to study food waste reduction strategies. ### Funding - Multiple funding allocations for conservation programs ($50 million/year for grazing land conservation, $1.5 billion for alternative manure management program). - $20 million/year for meat processing system resilience grants (Section 502). - $100 million/year for food waste-to-energy projects (Section 713). This legislation represents a holistic approach to creating a more sustainable food system that addresses climate change, reduces food waste, supports farmers and ranchers, and improves consumer understanding of food labeling.

Maddy summaryThis bill requires most private health insurance plans to cover diagnostic and supplemental breast exams with no out-of-pocket costs (like deductibles or copays) for enrolled patients. It specifically covers exams used to evaluate abnormalities found in screenings (diagnostic) or for high-risk screening without abnormalities (supplemental), based on medical guidelines. Plans can still require prior authorization for these exams, and state laws offering stronger protections remain in effect. The rule takes effect for plan years starting January 1, 2026.

Maddy summaryHR 3045, the West Bank Violence Prevention Act of 2025, imposes U.S. sanctions on foreign individuals and entities responsible for violence, displacement, or property destruction in the West Bank. It targets those directly involved in attacks on civilians, forced displacement, or property seizures, including settler leaders or officials of groups engaged in such activities. Key provisions require freezing assets of sanctioned individuals within U.S. jurisdiction and blocking their entry into the United States via visa restrictions. The law applies to foreign nationals meeting specific criteria outlined in the bill, not U.S. citizens or entities.

Hot Foods Act of 2025 This bill expands the Supplemental Nutrition Assistance Program (SNAP) to permit the use of SNAP benefits to purchase hot foods or hot food products ready for immediate consumption.

Maddy summaryThe Fight Fentanyl Act increases annual funding for fentanyl-related law enforcement efforts to $333 million from 2025 through 2030. It requires the Office of National Drug Control Policy to report annually on how HIDTA (High Intensity Drug Trafficking Area) funds target fentanyl trafficking, including seizure data and threat assessments. The bill also mandates the Attorney General to prioritize fentanyl prosecutions by temporarily reassigning U.S. attorneys to these cases. These provisions directly affect federal, state, local, and tribal law enforcement agencies working on fentanyl interdiction and prosecution.

Maddy summaryHR 2947, the Deafblind DATA Act, requires the U.S. Census Bureau to publish an annual data table starting in 2026 showing individuals who reported both hearing and vision loss in the American Community Survey. The table will include demographic details (sex, race, age) and economic factors (employment, education, income, poverty status) for people in each state, without revealing personal identifiers. This bill directly addresses the lack of centralized data on the deafblind population (estimated at 10,000 children and 40,000 adults by the National Center on Deafblindness), which currently prevents accurate service planning. The Census Bureau must also report to Congress within 180 days on feasibility of expanding such data collection. The Act does not change existing services but aims to improve understanding of this population's needs through better data.

Maddy summaryThe DRIVE Act of 2025 requires the Department of Veterans Affairs (VA) to set mileage reimbursement rates for veterans at the federal government's current standard rate for employees using personal vehicles on official business, replacing the previous fixed rate of 41.5 cents per mile. It also mandates that the VA process and pay these reimbursements within 90 days of a veteran's valid request. This directly affects veterans who travel for VA medical appointments or services using their personal vehicles. The bill aligns veteran travel reimbursements with federal employee standards and ensures timely payments.

Maddy summaryThis bill prohibits the federal government from issuing new oil and gas leases for exploration, development, or production in the Mid-Atlantic region of the Outer Continental Shelf. It specifically blocks leasing in the area defined by the 2023 federal leasing plan (2024-2029 National Outer Continental Shelf Oil and Gas Leasing Proposed Final Program). The law directly affects energy companies seeking to drill in this coastal zone and requires the Secretary of the Interior to halt such lease sales. It does not impact existing leases or operations already authorized.

Maddy summaryThe GOSAFE Act prohibits the sale, manufacture, transfer, and possession of gas-operated semi-automatic firearms and large capacity ammunition feeding devices (those holding more than 10 rounds). It defines gas-operated firearms as those that use gas from fired cartridges to cycle the action, requiring the Attorney General to publish a list of prohibited firearms within 180 days. The bill establishes a process for manufacturers to seek approval for new firearm designs before selling to civilians and creates a "Firearm Safety Trust Fund" to cover related costs. Certain firearms are exempt, including single-shot, muzzle-loading, and firearms with permanently fixed magazines holding 10 or fewer rounds. Violations could result in fines up to $5,000 or up to 12 months in prison.

Maddy summaryHR 2767, the BRAIN Act, aims to advance brain tumor research and improve patient care by requiring the NIH to create a public database of tumor samples collected with federal funding. It authorizes $50 million annually for a Glioblastoma Therapeutics Network to accelerate treatment development and $10 million for cellular immunotherapy research (including CAR-T therapies) targeting brain tumors. The bill also mandates a national awareness campaign to increase understanding of cancer clinical trials and biomarker testing, plus $5 million yearly for pilot programs studying survivor care coordination and follow-up services. Additionally, it directs the FDA to issue guidance ensuring brain tumor patients can access clinical trials. These provisions directly affect patients, researchers, and healthcare providers focused on brain tumors and rare cancers.